Sandoz infringed expired Lexapro patent, judge rules

Intellectual Property 2018-11-29 1:48 pm By Christine Caulfield | Melbourne

Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.